Status unknownAge-related condition

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Parallel-Group Clinical Trial of Qianggu Capsule in the Treatment of Comorbid Postmenopausal Osteoporosis (PMOP) and Knee Osteoarthritis (KOA) with Kidney-Yang Deficiency Syndrome

A Study on the Clinical Efficacy and Multidimensional Dynamic Mechanisms of Qianggu Capsule for Comorbid PMOP and KOA

Sponsor

Institute of Basic Research in Clinical Medicine, China Academy of Chinese Medical Sciences

Enrolment

60 planned

Conditions

Postmenopausal Osteoporosis; FB83.11

Interventions

Qianggu Capsule + basic treatment (Caltrate D + Celecoxib Capsules); Qianggu Capsule placebo + basic treatment (Caltrate D + Celecoxib Capsules)

Ages

adults, older adults

Registry

ITMCTR2026001750

Full record on ITMCTRSource: WHO ICTRP, processed 3 August 2026